The molecular imaging approach to image infections and inflammation by nuclear medicine techniques
Tóm tắt
Từ khóa
Tài liệu tham khảo
de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842–8.
Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:835–41.
Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol. 2004;32:47–57.
Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med. 1984;14:296–323.
Perkins PJ. Early gallium-67 abdominal imaging: pitfalls due to bowel activity. AJR Am J Roentgenol. 1981;136:1016–7.
Rizzello A, Di Pierro D, Lodi F, Trespidi S, Cicoria G, Pancaldi D, et al. Synthesis and quality control of 68 Ga citrate for routine clinical PET. Nucl Med Commun. 2009;30:542–5.
Datz FL. Indium-111-labeled leukocytes for the detection of infection: current status. Semin Nucl Med. 1994;24:92–109.
Papos M, Nagy F, Narai G, Rajtar M, Szantai G, Lang J, et al. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Dig Dis Sci. 1996;41:412–20.
Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev. 2010;110:3112–45.
Liberatore M, Clemente M, Iurilli AP, Zorzin L, Marini M, Dirocco E, et al. Scintigraphic evaluation of disease-activity in rheumatoid-arthritis—a comparison of Tc-99M human nonspecific immunoglobulins, leukocytes and albumin nanocolloids. Eur J Nucl Med. 1992;19:853–7.
van der Laken CJ, Boerman OC, Oyen WJG, Laverman P, van de Ven MTP, Corstens FHM, et al. In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions. J Infect Dis. 1998;177:1398–401.
Barrera P, van der Laken CJ, Oven WJG, van de Putte LBA, Corstens FHM. Radiolabeled IL-1ra for detection of synovitis in patients with RA Preliminary results. Arthritis Rheum. 1998;41:S37.
van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, van der Meer JWM, Corstens FHM. Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study. Eur J Nucl Med. 1998;25:347–52.
Gratz S, Rennen H, Boerman O, Oyen W, Corstens F. Rapid imaging of experimental colitis with 99mTc-interleukin-8 in rabbits. Eur J Nucl Med. 2001;28:1044.
Gratz S, Rennen HJJM, Boerman OC, Oyen WJG, Burma P, Corstens FHM. Tc-99m-interleukin-8 for imaging acute osteomyelitis. J Nucl Med. 2001;42:1257–64.
Rennen HJ, Boerman OC, Frielink C, Oyen WJ, Corstens FH. Kinetics of Tc-99m-labeled interleukin-8 in inflammation and infection. J Nucl Med. 2003;44:153P.
Chianelli M, Boerman OC, Malviya G, Galli F, Oyen WJG, Signore A. Receptor binding ligands to image infection. Curr Pharm Des. 2008;14:3316–25.
Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, de Murphy CA, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of Tc-99m-UBI 29–41 in humans. Nucl Med Biol. 2004;31:373–9.
Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EKJ, Calame W. Imaging of bacterial infections with Tc-99m-labeled human neutrophil peptide-1. J Nucl Med. 1999;40:2073–80.
Welling MM, Paulusma-Annema A, Balter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301.
Rusckowski M, Gupta S, Liu GZ, Dou SP, Hnatowich DJ. Investigation of four Tc-99m-labeled bacteriophages for infection-specific imaging. Nucl Med Biol. 2008;35:433–40.
Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin—an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med. 1992;33:1810–5.
Lambrecht FY. Evaluation of Tc-99m-labeled antibiotics for infection detection. Ann Nucl Med. 2011;25:1–6.
Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, et al. Imaging bacterial infection with Tc-99m-ciprofloxacin (Infecton). J Clin Pathol. 2002;55:817–23.
Solanki KK, Das SS, Britton KE. Infection is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol Imaging. 2003;30:181–2.
Lupetti A, Welling MM, Mazzi U, Nibbering PH, Pauwels EKJ. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging. 2002;29:674–9.
Thakur ML, Mcafee JG. The significance of chromosomal-aberrations in indium-111-labeled lymphocytes. J Nucl Med. 1984;25:922–7.
Forstrom LA, Dunn WL, Mullan BP, Hung JC, Lowe VJ, Thorson LM. Biodistribution and dosimetry of [F-18]fluorodeoxyglucose labelled leukocytes in normal human subjects. Nucl Med Commun. 2002;23:721–5.
Palestro CJ, Love C, Miller TT. Diagnostic imaging tests and microbial infections. Cellular Microbiology. 2007;9:2323–33.
Rennen HJJM, Boerman OC, Oyen WJG, Corstens FHM. Imaging infection/inflammation in the new millennium. Eur J Nucl Med. 2001;28:241–52.
Skehan SJ, White JF, Evans JW, Parry-Jones DR, Solanki CK, Ballinger JR, et al. Mechanism of accumulation of Tc-99m-sulesomab in inflammation. J Nucl Med. 2003;44:11–8.
Bleeker-Rovers CP, Vos FJ, Corstens FHM, Oyen WJG. Imaging of infectious diseases using [F-18]fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008;52:17–29.
Larikka MJ, Ahonen AK, Junila JA, Niemela O, Hamalainen MM, Syrjala HP. Extended combined Tc-99m-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections. Eur J Nucl Med. 2001;28:288–93.
Liberatore M, Iurilli AP, Ponzo F, Prosperi D, Santini C, Baiocchi P, et al. Clinical usefulness of technetium-99m-HMPAO-labeled leukocyte scan in prosthetic vascular graft infection. J Nucl Med. 1998;39:875–9.
Peters AM. The utility of [Tc-99M] HMPAO-leukocytes for imaging infection. Semin Nucl Med. 1994;24:110–27.
Castaigne C, Tondeur M, De Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009;30:41–7.
Glaudemans AW, Signore A. FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging. 2010;37:1986–91.
Glaudemans AWJM, Maccioni F, Mansi L, Dierckx RAJO, Signore A. Imaging of cell trafficking in Crohn’s disease. J Cell Physiol. 2010;223:562–71.
Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging. 2009;53:105–23.
van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJG. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3–15.
Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66–78.
Cerqueira MD, Jacobson AF, Matsuda M, Stratton JR. In-111 leukocyte scintigraphic detection of mitral-valve vegetations in active bacterial-endocarditis. Am J Cardiol. 1989;64:1080–1.
Morguet AJ, Munz DL, Ivancevic V, Werner GS, Sandrock D, Bokemeier M, et al. Immunoscintigraphy using Tc-99M-labeled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Coll Cardiol. 1994;23:1171–8.
Peltier P, Potel G, Lovat E, Baron D, Chatal JF. Detection of lung and bone infection with antigranulocyte monoclonal-antibody BW-250/183 radiolabeled with Tc(M)-99. Nucl Med Commun. 1993;14:766–74.
Dominguezgadea L, Martincurto LM, Delacalle H, Crespo A. Diabetic foot infections - scintigraphic evaluation with Tc-99(M)-labeled antigranulocyte antibodies. Nucl Med Commun. 1993;14:212–8.
Boubaker A, Delaloye AB, Blanc CH, Dutoit M, Leyvraz PF, Delaloye B. Immunoscintigraphy with antigranulocyte monoclonal-antibodies for the diagnosis of septic loosening of hip prostheses. Eur J Nucl Med. 1995;22:139–47.
Klett R, Kordelle J, Stahl U, Khalisi A, Puille M, Steiner D, et al. Immunoscintigraphy of septic loosening of knee endoprosthesis: a retrospective evaluation of the antigranulocyte antibody BW 250/183. Eur J Nucl Med Mol Imaging. 2003;30:1463–6.
Scheidler J, Leinsinger G, Pfahler M, Kirsch CM. Diagnosis of osteomyelitis—accuracy and limitations of antigranulocyte antibody imaging compared to 3-phase bone-scan. Clin Nucl Med. 1994;19:731–7.
Gratz S, Braun HG, Behr TM, Meller J, Herrmann A, Conrad M, et al. Photopenia in chronic vertebral osteomyelitis with Tc-99m antigranulocyte antibody (BW 250/183). J Nucl Med. 1997;38:494.
Gyorke T, Duffek L, Bartfai K, Mako E, Karlinger K, Mester A, et al. The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aspecific bowel activity using immunoscintigraphy with Tc-99m anti-granulocyte antibodies. Eur J Radiol. 2000;35:183–92.
Mahida YR, Perkins AC, Frier M, Wastie ML, Hawkey CJ. Monoclonal antigranulocyte antibody imaging in inflammatory bowel-disease—a preliminary report. Nucl Med Commun. 1992;13:330–5.
Becker W, Dolkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med. 1993;20:1078–83.
Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, Becker W. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med. 1998;39:1248–53.
Gratz S, Behr TM, Herrmann A, Meller J, Conrad M, Zappel H, et al. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl Med Commun. 1998;19:1037–45.
Gratz S, Behr T, Herrmann A, Dresing K, Tarditi L, Franceschini R, et al. Intraindividual comparison of Tc-99m-labelled anti-SSEA-1 antigranulocyte antibody and Tc-99m-HMPAO labelled white blood cells for the imaging of infection. Eur J Nucl Med. 1998;25:386–93.
Thakur ML, Marcus CS, Henneman P, Butler J, Sinow R, Diggles L, et al. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1. J Nucl Med. 1996;37:1789–95.
Thakur ML, Marcus CS, Kipper SL, Ahdoot R, Diggles L, Pham HL, et al. Imaging infection with LeuTech (R). Nucl Med Commun. 2001;22:513–9.
Rypins EB, Kipper SL. Scintigraphic determination of equivocal appendicitis. Am Surg. 2000;66:891–5.
Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, et al. Detection of soft-tissue infections and osteomyelitis using a Tc-99M-labeled antigranulocyte monoclonal-antibody fragment. J Nucl Med. 1994;35:1436–43.
Becker W, Palestro CJ, Winship J, Feld T, Pinsky CM, Wolf F, et al. Rapid imaging of infections with a monoclonal antibody fragment. Clin Orthopaed Relat Res. 1996;(329):263–72.
Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C, Girault S, et al. Comparison of Tc-99m-labelled antileukocyte fragment Fab’ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun. 2000;21:747–53.
Gratz S, Schipper ML, Dorner J, Hoffken H, Becker W, Kaiser JW, et al. LeukoScan for imaging infection in different clinical settings—a retrospective evaluation and extended review of the literature. Clin Nucl Med. 2003;28:267–76.
Harwood SJ, Valdivia S, Hung GL, Quenzer RW. Use of sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis. 1999;28:1200–5.
Barron B, Hanna C, Passalaqua AM, Lamki L, Wegener WA, Goldenberg DM. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab’ fragment. Surgery. 1999;125:288–96.
Gratz S, Raddatz D, Hagenah G, Behr T, Behe M, Becker W. (TC)-T-99m-labelled antigranulocyte monoclonal antibody FAB’ fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol. 2000;75:75–84.
Stokkel MPM, Reigman HIE, Pauwels EKJ. Scintigraphic head-to-head comparison between Tc-99m-WBCs and Tc-99m-LeukoScan in the evaluation of inflammatory bowel disease: a pilot study. Eur J Nucl Med Mol Imaging. 2002;29:251–4.
Basu S, Chryssikos T, Moghadam-Kia S, Zhuang HM, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36–51.
Bleeker-Rovers CP, de Kleijn EMHA, Corstens FHM, van der Meer JWM, Oyen WJG. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37.
Jasper N, Dabritz J, Frosch M, Loeffler M, Weckesser M, Foell D. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging. 2010;37:136–45.
Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504–11.
Basu S, Zhuang HM, Torigian DA, Rosenbaum J, Chen WG, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124–45.
Loffler M, Weckesser M, Franzius C, Schober O, Zimmer KP. High diagnostic value of F-18-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci. 2006;1072:379–85.
Ito K, Kubota K, Morooka M, Hasuo K, Kuroki H, Mimori A. Clinical impact of F-18-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nucl Med Commun. 2010;31:691–8.
Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging. 2009;53:35–40.
Zerizer I, Tan K, Khan S, Barwick T, Marzola MC, Rubello D, et al. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol. 2010;73:504–9.
Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P. Pericystic metabolic activity in alveolar echinococcosis: Assessment and follow-up by positron emission tomography. Clin Infect Dis. 1999;29:1157–63.
Bleeker-Rovers CP, de Sevaux RGL, van Hamersvelt HW, Corstens FHM, Oyen WJG. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003;41:E18–21.
ODoherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575–83.
Knockaert DC, Mortelmans LA, Deroo MC, Bobbaers HJ. Clinical-value of Ga-67 scintigraphy in evaluation of fever of unknown origin. Clin Infect Dis. 1994;18:601–5.
Marienhagen J, Hennemann B, Andreesen R, Eilles C. In-111-oxine labeling of tumor-cytotoxic macrophages generated in vitro from circulating blood monocytes—an in vitro evaluation. Nucl Med Commun. 1995;16:357–61.
van Hemert FJ, Thurlings R, Dohmen SE, Voennansc C, Tak PP, Eck-Smit BLF, et al. Labeling of autologous monocytes with Tc-99m-HMPAO at very high specific radioactivity. Nucl Med Biol. 2007;34:933–8.
van Hemert FJ, Voermans C, Eck-Smit BLF, Bennink RJ. Labeling monocytes for imaging chronic inflammation. Q J Nucl Med Mol Imaging. 2009;53:78–88.
Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, et al. [C-11](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology. 1999;53:2199–203.
Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, Kreutzberg GW, et al. In vivo visualization of activated glia by [C-11] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain. 2001;124:2014–27.
Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, et al. Imaging glial cell activation with [C-11]-R-PK11195 in patients with AIDS. J Neurovirol. 2005;11:346–55.
Tahara N, Imaizumi T, Virmani R, Narula J. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med. 2009;50:331–4.
Tokita N, Hasegawa S, Maruyama K, Izumi T, Blankenberg FG, Tait JF, et al. Tc-99m-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging. 2003;30:232–8.
Annovazzi A, D’Alessandria C, Bonanno E, Mather SJ, Cornelissen B, van de Wiele C, et al. Synthesis of Tc-99m-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. Eur J Nucl Med Mol Imaging. 2006;33:474–82.
Glaudemans AW, Dierckx RA, Kallenberg CG, Anzola Fuentes KL. The role of radiolabelled anti-TNFa monoclonal antibodies for diagnostic purposes and therapy evaluation. Q J Nucl Med Mol Imaging. 2010;54:639–53.
Malviya G, D’Alessandria C, Bonanno E, Vexler V, Massari R, Trotta C, et al. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes. J Nucl Med. 2009;50:1683–91.
Prager E, Wehrschuetz M, Bisail B, Woltsche M, Schwarz T, Lanz H, et al. Comparison of F-18-FDG and Ga-67-citrate in sarcoidosis imaging. Nuklearmedizin (Nucl Med). 2008;47:18–23.
Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949–53.
Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with F-18-FDG PET. J Nucl Med. 2004;45:956–64.
Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR-imaging and PET with 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology. 1995;196:647–55.
Chianelli M, D’Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A, et al. New radiopharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med Mol Imaging. 2006;50:217–25.
Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo F-18-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818–24.
Rudd JHF, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009–16.
Glaudemans AWJM, Slart RHJA, Bozzao A, Bonanno E, Arca M, Dierckx RAJO, et al. Molecular imaging in atherosclerosis. Eur J Nucl Med Mol Imaging. 2010;37:2381–97.
Kinne RW, Becker W, Simon G, Paganelli G, PalomboKinne E, Wolski A, et al. Joint uptake and body distribution of a Tc-99M-labeled anti-rat-CD4 monoclonal-antibody in rat adjuvant arthritis. J Nucl Med. 1993;34:92–8.
Kinne RW, Becker W, Koscheck T, Kuhlmann J, Sharkey RM, Behr T, et al. Rat adjuvant arthritis - imaging with technetium-99M-anti-CD4 Fab’ fragments. J Nucl Med. 1995;36:2268–75.
Kinne RW, Becker W, Schwab J, Horneff G, Schwarz A, Kalden JR, et al. Comparison of (99)Tcm-labeled specific murine anti-CD4 monoclonal-antibodies and nonspecific human-immunoglobulin for imaging inflamed joints in rheumatoid-arthritis. Nucl Med Commun. 1993;14:667–75.
Kinne RW, Wolski A, Palombo-Kinne E, Wolf F, Emmrich F, Becker W. Minimal contribution of cell-bound antibodies to the immunoscintigraphy of inflamed joints with Tc-99m-anti-CD4 monoclonal antibodies. Nuklearmedizin (Nucl Med). 2002;41:129–34.
Dalessandria C, Malviya G, Viscido A, Aratari A, Maccioni F, Amato A, et al. Use of a Tc-99m labeled anti-TNF alpha monoclonal antibody in Crohn’s disease: in vitro and in vivo studies. Q J Nucl Med Mol Imaging. 2007;51:334–42.
Conti F, Priori R, Chimenti MS, Coari G, Annovazzi A, Valesini G, et al. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy—a role for scintigraphy with Tc-99m-infliximab. Arthritis Rheum. 2005;52:1224–6.
Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging. 2010;37:386–98.
Lucia P, Parisella MG, Danese C, Bruno F, Manetti LL, Capriotti G, et al. Diagnosis and followup of Takayasu’s arteritis by scintigraphy with radiolabelled interleukin 2. J Rheumatol. 2004;31:1225–7.
Signore A, Chianelli M, Toscano A, Monetini L, Ronga G, Nimmon CC, et al. A radiopharmaceutical for imaging areas of lymphocytic infiltration—I-125 interleukin-2—labeling procedure and animal studies. Nucl Med Commun. 1992;13:713–22.
Signore A, Chianelli M, Ferretti E, Tomei E, Pozzilli P, Ronga G, et al. Detection of pancreatic insulitis in type-1 diabetes by using 123I-labeled interleukin-2. Eur J Nucl Med. 1992;19:583.
Signore A, Chianelli M, Parisella MG, Capriotti G, Giacalone P, Di Leve G, et al. In vivo imaging of insulitis in autoimmune diabetes. J Endocrinol Invest. 1999;22:151–8.
Chianelli M, Parisella MG, Visalli N, Mather SJ, D’Alessandria C, Pozzilli P, et al. Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev. 2008;24:115–22.
Signore A, Chianelli M, Annovazzi A, Rosi M, Maiuri L, Greco M, et al. Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. Eur J Nucl Med. 2000;27:18–24.
Signore A, Chianelli M, Annovazzi A, Bonanno E, Spagnoli LG, Pozzilli P, et al. I-123-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn’s disease. J Nucl Med. 2000;41:242–9.
Annovazzi A, Biancone L, Caviglia R, Chianelli M, Capriotti G, Mather SJ, et al. Tc-99m-interleukin-2 and Tc-99m-HMPAO granulocyte scintigraphy in patients with inactive Crohn’s disease. Eur J Nucl Med Mol Imaging. 2003;30:374–82.
Signore A, Annovazzi A, Barone R, Bonanno E, D’Alessandria C, Chianelli M, et al. Tc-99m-Interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. J Nucl Med. 2004;45:1647–52.
Procaccini E, Chianelli M, Pantano P, Signore A. Imaging of autoimmune diseases. Q J Nucl Med. 1999;43:100–12.
Chianelli M, Mather SJ, Grossman A, Sobnak R, Fritzberg A, Britton KE, et al. Tc-99m-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study. Eur J Nucl Med Mol Imaging. 2008;35:2286–93.